Table 1.
Demographics and treatment-related characteristics
| Factor | Total Cohort |
|---|---|
| (n = 621) | |
| Number (%) | |
| Age* | 53.0 (26.2, 83.6) |
| BMI* | 26.0 (15.8, 50.4) |
| BMI > 25 | 356 (57.3%) |
| Missing Data | 2 |
| Surgery | |
| Mastectomy with Reconstruction | 222 (35.7%) |
| Mastectomy without Reconstruction | 51 (8.2%) |
| Lumpectomy | 348 (56.0%) |
| Nodal surgery | |
| Axillary Lymph Node Dissection | 176 (28.3%) |
| Sentinel Lymph Node Biopsy | 393 (63.3%) |
| No Nodal Surgery | 52 (8.4%) |
| Regional Lymph Node Radiation | 188 (30.3%) |
| Neoadjuvant ± adjuvant chemotherapy | 109 (17.6%) |
| Adjuvant chemotherapy, only | 196 (31.6%) |
| Time between breast surgery & first dose* | 69.0 months (0.13, 361.5) |
*median (range)